Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial-Reference-Cited by-同舟云学术

Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial

Published:2019-04-09 Issue:5 Volume:42 Page:568-571
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Guimarães Patricia O.¹,Pokorney Sean D.¹,Lopes Renato D.¹^ORCID,Wojdyla Daniel M.¹,Gersh Bernard J.²,Giczewska Anna¹³,Carnicelli Anthony¹,Lewis Basil S.⁴,Hanna Michael⁵,Wallentin Lars⁶,Vinereanu Dragos⁷,Alexander John H.¹,Granger Christopher B.¹

Affiliation:

1. Duke Clinical Research InstituteDuke University School of Medicine Durham North Carolina

2. Division of Cardiovascular DiseasesMayo Clinic College of Medicine Rochester Minnesota

3. Department of Biomedical Engineering, Faculty of ElectronicsTelecommunications and Informatics, Gdansk University of Technology Poland

4. Department of Cardiovascular MedicineLady Davis Carmel Medical Center Haifa Israel

5. Bristol‐Myers Squibb Princeton New Jersey

6. Uppsala Clinical Research Center, Department of Medical Sciences, CardiologyUppsala University Uppsala Sweden

7. Department of CardiologyUniversity of Medicine and Pharmacy Carol Davila, University and Emergency Hospital Bucharest Romania

Funder

Bristol-Myers Squibb

Pfizer

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/clc.23178

Reference5 articles.

1. What is ‘valvular’ atrial fibrillation? A reappraisal

2. Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves

3. Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves

4. Apixaban versus Warfarin in Patients with Atrial Fibrillation

5. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical effects of direct oral anticoagulants in elderly patients with a bioprosthetic valve and atrial fibrillation;International Journal of Cardiology;2024-10

2. The balance between thrombosis and bleeding after mitral valve surgery: The need for robust evidence;Revista Portuguesa de Cardiologia;2024-09

3. Non-vitamin K versus vitamin K antagonist oral anticoagulants in surgical mitral valve repair or bioprosthetic valve replacement in the first three months after surgery;Revista Portuguesa de Cardiologia;2024-09

4. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Compared with Vitamin K Antagonists in Patients with Atrial Fibrillation and Type 2 Valvular Heart Disease: A Systematic Review and Meta-Analysis;Cardiovascular Drugs and Therapy;2024-08-17

5. Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early After Surgical Bioprosthetic Valve Replacement: Rationale and Design of the ENBALV Trial;Cardiovascular Drugs and Therapy;2024-06-24